CL2019002661A1 - Compuestos antineoplásicos. - Google Patents
Compuestos antineoplásicos.Info
- Publication number
- CL2019002661A1 CL2019002661A1 CL2019002661A CL2019002661A CL2019002661A1 CL 2019002661 A1 CL2019002661 A1 CL 2019002661A1 CL 2019002661 A CL2019002661 A CL 2019002661A CL 2019002661 A CL2019002661 A CL 2019002661A CL 2019002661 A1 CL2019002661 A1 CL 2019002661A1
- Authority
- CL
- Chile
- Prior art keywords
- similar
- compounds
- phm005
- strain
- antineoplastic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/38—Pseudomonas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382140 | 2017-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2019002661A1 true CL2019002661A1 (es) | 2019-12-27 |
Family
ID=58398130
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2019002661A CL2019002661A1 (es) | 2017-03-17 | 2019-09-16 | Compuestos antineoplásicos. |
| CL2021000117A CL2021000117A1 (es) | 2017-03-17 | 2021-01-14 | Compuestos antineoplásicos (divisional de la solicitud 2661-2019). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2021000117A CL2021000117A1 (es) | 2017-03-17 | 2021-01-14 | Compuestos antineoplásicos (divisional de la solicitud 2661-2019). |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20210317490A1 (https=) |
| EP (1) | EP3596068A1 (https=) |
| JP (1) | JP7209633B2 (https=) |
| KR (1) | KR102547649B1 (https=) |
| CN (1) | CN110650954B (https=) |
| AU (2) | AU2018235140B2 (https=) |
| BR (1) | BR112019019301A2 (https=) |
| CA (1) | CA3056725A1 (https=) |
| CL (2) | CL2019002661A1 (https=) |
| IL (2) | IL292572A (https=) |
| MA (1) | MA49880A (https=) |
| MX (2) | MX392144B (https=) |
| MY (2) | MY202630A (https=) |
| SG (1) | SG11201908267XA (https=) |
| UA (1) | UA126338C2 (https=) |
| WO (1) | WO2018167270A1 (https=) |
| ZA (2) | ZA201906518B (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12156523B2 (en) | 2017-03-17 | 2024-12-03 | Mmag Co., Ltd. | Plant disease control agent |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114615999B (zh) * | 2019-09-05 | 2024-03-08 | 法马马有限公司 | 药物抗体偶联物 |
| CN112661808B (zh) * | 2020-12-23 | 2022-05-27 | 浙江大学 | 一种酯肽类化合物及其制备方法和应用 |
| EP4326869A4 (en) * | 2021-04-20 | 2025-12-10 | Univ Of Louisville | RECOMBINATING MICRO-NECK |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2040338T3 (es) | 1987-04-29 | 1993-10-16 | Harbor Branch Oceanographic Institution, Inc. | Compuestos antitumorales y antiviricos de origen marino. |
| US4801606A (en) | 1987-07-17 | 1989-01-31 | Harbor Branch Oceanographic Institution Inc. | Antiviral compositions |
| EP1448767B1 (en) | 2001-11-22 | 2010-10-13 | Rheinische Friedrich-Wilhelms-Universität Bonn | Novel gene cluster of pederin biosynthesis genes |
| WO2013016120A1 (en) | 2011-07-22 | 2013-01-31 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Pederin and psymberin agents |
-
2018
- 2018-03-16 JP JP2019550649A patent/JP7209633B2/ja active Active
- 2018-03-16 BR BR112019019301-4A patent/BR112019019301A2/pt unknown
- 2018-03-16 WO PCT/EP2018/056665 patent/WO2018167270A1/en not_active Ceased
- 2018-03-16 MY MYPI2022001729A patent/MY202630A/en unknown
- 2018-03-16 CN CN201880018986.1A patent/CN110650954B/zh not_active Expired - Fee Related
- 2018-03-16 SG SG11201908267X patent/SG11201908267XA/en unknown
- 2018-03-16 MX MX2019010890A patent/MX392144B/es unknown
- 2018-03-16 AU AU2018235140A patent/AU2018235140B2/en not_active Ceased
- 2018-03-16 UA UAA201910399A patent/UA126338C2/uk unknown
- 2018-03-16 US US16/494,720 patent/US20210317490A1/en not_active Abandoned
- 2018-03-16 CA CA3056725A patent/CA3056725A1/en active Pending
- 2018-03-16 IL IL292572A patent/IL292572A/en unknown
- 2018-03-16 MY MYPI2019005105A patent/MY195435A/en unknown
- 2018-03-16 MA MA049880A patent/MA49880A/fr unknown
- 2018-03-16 EP EP18711108.3A patent/EP3596068A1/en not_active Withdrawn
- 2018-03-16 KR KR1020197030504A patent/KR102547649B1/ko active Active
-
2019
- 2019-09-12 MX MX2021011385A patent/MX2021011385A/es unknown
- 2019-09-15 IL IL269353A patent/IL269353B/en unknown
- 2019-09-16 CL CL2019002661A patent/CL2019002661A1/es unknown
- 2019-10-03 ZA ZA2019/06518A patent/ZA201906518B/en unknown
-
2020
- 2020-10-05 ZA ZA2020/06147A patent/ZA202006147B/en unknown
-
2021
- 2021-01-14 CL CL2021000117A patent/CL2021000117A1/es unknown
- 2021-12-01 AU AU2021277683A patent/AU2021277683B2/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12156523B2 (en) | 2017-03-17 | 2024-12-03 | Mmag Co., Ltd. | Plant disease control agent |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190129950A (ko) | 2019-11-20 |
| MX2019010890A (es) | 2019-12-19 |
| IL269353B (en) | 2022-06-01 |
| AU2018235140B2 (en) | 2021-11-11 |
| JP2020510065A (ja) | 2020-04-02 |
| CA3056725A1 (en) | 2018-09-20 |
| CN110650954B (zh) | 2023-11-03 |
| IL269353A (en) | 2019-11-28 |
| WO2018167270A1 (en) | 2018-09-20 |
| RU2019132808A3 (https=) | 2021-10-04 |
| AU2021277683A1 (en) | 2021-12-23 |
| JP7209633B2 (ja) | 2023-01-20 |
| IL292572A (en) | 2022-06-01 |
| CN110650954A (zh) | 2020-01-03 |
| US20210317490A1 (en) | 2021-10-14 |
| AU2018235140A1 (en) | 2019-10-03 |
| AU2021277683B2 (en) | 2023-03-09 |
| MX2021011385A (es) | 2021-10-13 |
| MX392144B (es) | 2025-03-21 |
| CL2021000117A1 (es) | 2021-07-30 |
| MA49880A (fr) | 2020-06-24 |
| MY202630A (en) | 2024-05-10 |
| EP3596068A1 (en) | 2020-01-22 |
| KR102547649B1 (ko) | 2023-06-23 |
| UA126338C2 (uk) | 2022-09-21 |
| MY195435A (en) | 2023-01-20 |
| RU2019132808A (ru) | 2021-04-19 |
| ZA201906518B (en) | 2021-01-27 |
| SG11201908267XA (en) | 2019-10-30 |
| BR112019019301A2 (pt) | 2020-04-28 |
| ZA202006147B (en) | 2023-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR125320A2 (es) | Compuesto cristalino, método de preparación y composición que lo comprende | |
| CL2020001048A1 (es) | Anticuerpos monoclonales contra bcma. (divisional solicitud 201800281) | |
| CL2018003323A1 (es) | Piridinas sustituidas con heteroarilo y métodos de uso. | |
| CL2018000952A1 (es) | Compuestos útiles como inmunomoduladores | |
| CR20160419A (es) | Nuevos compuestos biciclicos | |
| GT201700189A (es) | Derivados de nucleósidos sustituidos útiles como agentes antineoplásicos | |
| BR112015011760A2 (pt) | composto, uso do composto, e uso de uma composição farmacêutica | |
| CL2019002661A1 (es) | Compuestos antineoplásicos. | |
| BR112016028476A8 (pt) | compostos, composição, uso de um composto e método para o combate dos fungos nocivos | |
| MX376028B (es) | Nuevos derivados de amonio, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| JOP20200110A1 (ar) | متبلورات مضادة جديدة لسلسلة من مركبات مضادة للفيروسات | |
| CR20180072A (es) | Nuevos compuestos biciclicos como inhibidores de atx | |
| DOP2015000270A (es) | Potenciador de inhibidores del homólogo de zeste | |
| EA201591497A1 (ru) | Новые производные октагидропирроло[3,4-c]пиррола и их аналоги в качестве ингибиторов аутотаксина | |
| ECSP18074962A (es) | Derivados de aminotiazol útiles como agentes antivíricos | |
| SV2016005149A (es) | Polimorfo de los inhibidores de la syk | |
| AR069474A1 (es) | Material anticorrosivo | |
| GT201400111A (es) | Triazolopiridinas sustituidas | |
| GT201700190A (es) | Desacetoxitubulisina h y análogos de esta | |
| MX386008B (es) | Compuestos citotóxicos y antimitóticos, y métodos para utilizarlos. | |
| CL2016003074A1 (es) | Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer. | |
| MX2017014459A (es) | Compuestos de tioeter como inhibidores de la nitrificacion. | |
| MX2018005379A (es) | Compuestos de criptoficina novedosos y productos conjugados, su preparacion y su uso terapeutico. | |
| EA202090978A1 (ru) | Новые макроциклические производные, способ их получения и содержащие их фармацевтические композиции | |
| PY18111999A (es) | Hidroxiisoxazolinas y derivados de estos |